Zenas Biopharma is a startup based in the United States, 1 tracked investor.
Zenas Biopharma is a startup based in the United States. Brouky records 1 investor associated with the company.
Zenas BioPharma is a clinical-stage biotechnology company developing immune-based therapies focused on autoimmune diseases using investigational drugs such as obexelimab and orelabrutinib.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.